“Spectral Domain Optical Coherence Tomography Predictors of Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2).”, Ophthalmol Retina, 2020.
, “Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.”, Ophthalmology, vol. 120, no. 1, pp. 140-50, 2013.
, “Spectral-Domain Optical Coherence Tomography Characteristics of Intermediate Age-Related Macular Degeneration”, Opthalmology, vol. 120, pp. 140-150, 2013.
, “Stability of Undiluted and Diluted Vaccinia-Virus Vaccine, Dryvax”, J Infectious Diseases, vol. 187, pp. 1319-1322, 2003.
, “Stability of undiluted and diluted vaccinia-virus vaccine, Dryvax.”, J Infect Dis, vol. 187, no. 8, pp. 1319-22, 2003.
, “Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9.”, Arch Ophthalmol, vol. 128, no. 9, pp. 1140-5, 2010.
, “The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4.”, Arch Ophthalmol, vol. 127, no. 11, pp. 1461-7, 2009.
, “Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Stereoscopic Color Fundus Photographs and Fluorescein Angiograms: SCORE Study Report 9”, Archives of Ophthalmology, vol. 128, pp. 1140-1145, 2010.
, “The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Optical Coherence Tomograms: SCORE Study Report 4”, Arch Ophthalmol, vol. 127, pp. 1461-1467, 2009.
, “Standardization and Validation Issues of the ELISPOT Assay”, Methods Mol Biol, vol. 302, pp. 51-86, 2005.
, “Standardization and validation issues of the ELISPOT assay.”, Methods Mol Biol, vol. 302, pp. 51-86, 2005.
, , “Statistical aspects of intraperitoneal chemotherapy studies.”, Semin Oncol, vol. 12, no. 3 Suppl 4, pp. 121-3, 1985.
, “Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.”, J Infect Dis, vol. 203, no. 7, pp. 969-75, 2011.
, “Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: a Case Study for Statistical Issues in Efficacy Trials”, J Infect Dis, vol. 203, pp. 969-975, 2011.
, “Statistical issues related to early closure of STOP-ROP, a group-sequential trial.”, Control Clin Trials, vol. 24, no. 1, pp. 28-38, 2003.
, “Statistical methods for determining prognosis in severe head injury.”, Neurosurgery, vol. 6, no. 3, pp. 243-8, 1980.
, “Stature in children with chronic kidney disease: analysis of NAPRTCS database.”, Pediatr Nephrol, vol. 21, no. 6, pp. 793-9, 2006.
, “Stature in Children With Chronic Kidney Disease: Analysis of NAPRTCS Database”, Pediatr Nephrol, vol. 21, pp. 793-799, 2006.
, , , “Steady improvement in renal allograft survival among North American children. A five year appraisal by the North American Pediatric Renal Transplant Cooperative Study,”, Kidney Int, vol. 48, pp. 551-53, 1995.
, “Steady improvement in renal allograft survival among North American children: a five year appraisal by the North American Pediatric Renal Transplant Cooperative Study.”, Kidney Int, vol. 48, no. 2, pp. 551-3, 1995.
, “Steady improvement in short-term graft survival of pediatric renal transplants: the NAPRTCS experience.”, Clin Transpl, pp. 95-110, 1999.
, “Steady improvement in short-term graft survival of pediatric renal transplants: the NAPRTCS experience”, Clin Transplant, pp. 95-110, 1999.
,